Dosing Schedule for People 12 Years of Age & Older(2024-2025 Formula)

COMIRNATY® (COVID-19 Vaccine, mRNA) is a vaccine for use in people 12 yearsof age and older to protect against coronavirus disease 2019 (COVID-19).
COMIRNATY does not contain SARS-CoV-2, the virus that causes COVID-19.
COMIRNATY cannot give you COVID-19.

COMIRNATY is FDA approved to be administered as a single dose (0.3 mL)
into the muscle for people 12 years of age and older. People previously
vaccinated with any COVID-19 vaccine should receive the dose ofCOMIRNATY at least 2 months after the last dose of COVID-19 vaccine.

If you are immunocompromised, talk to your healthcare provider.
Your immune response to COVID-19 vaccination may not be
as strong as people who are not immunocompromised.
Your healthcare provider may have different recommendations
for COVID-19 vaccinations.
COMIRNATY (2024-2025 Formula) is made using a similar
process as previous formulas, with the difference only inthe mRNA which encodes the viral spike protein of SARS-CoV-2
Omicron variant lineage KP.2.
Vaccination with COMIRNATY may not protect everyone.

SELECTED SAFETY INFORMATION
You should NOT get COMIRNATY® (COVID-19 Vaccine, mRNA) if you had a severe allergic reaction to a previous doseof COMIRNATY or any Pfizer-BioNTech COVID-19 vaccine or to any ingredient in these vaccines.

Don’t delay. Find a vaccine near you today. | COMIRNATY.COM/VACCINE-FINDER

Important Safety Information and Indication• You should NOT get COMIRNATY® (COVID-19 Vaccine, mRNA) if you had a severe allergic reaction to a previous dose ofCOMIRNATY or any Pfizer-BioNTech COVID-19 vaccine or to any ingredient in these vaccines• There is a remote chance that COMIRNATY could cause a severe allergic reaction. A severe allergic reaction would usually occur
within a few minutes to 1 hour after getting a dose. For this reason, your vaccination provider may ask you to stay at the place
where you received the vaccine for monitoring after vaccination. Signs of a severe allergic reaction can include:• Difficulty breathing• Swelling of your face and throat• A fast heartbeat• A bad rash all over the body
• Dizziness and weakness
Important Safety Information continues on the next page.
Please click here for full Prescribing Information
and Patient Information for COMIRNATY.

Important Safety Information and Indication (cont’d)• Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have occurredin some people who have received mRNA COVID-19 vaccines, including COMIRNATY and Pfizer-BioNTech COVID-19 vaccines.
Myocarditis and pericarditis following COMIRNATY have occurred most commonly in adolescent males 12 through 17 years ofage. In most of these individuals, symptoms began within a few days following vaccination. The chance of having this occur isvery low. You should seek medical attention right away if you or your child have any of the following symptoms after receiving
the vaccine, particularly during the 2 weeks after receiving a dose of the vaccine:• Chest pain
• Shortness of breath• Feelings of having a fast-beating, fluttering, or pounding heart• Fainting can happen after getting injectable vaccines including COMIRNATY. Your vaccination provider may ask you to sit or lie
down• People with weakened immune systems may have a reduced immune response to COMIRNATY• COMIRNATY may not protect all people who receive the vaccine
Before getting COMIRNATY, tell your vaccination provider about all of your medical conditions, including if you:• have any allergies• had a severe allergic reaction after receiving a previous dose of any COVID-19 vaccine• have had myocarditis (inflammation of the heart muscle) or pericarditis (inflammation of the lining outside the heart)• have a fever• have a bleeding disorder or are on a blood thinner• are immunocompromised or are on a medicine that affects your immune system• are pregnant, plan to become pregnant, or are breastfeeding• have received another COVID-19 vaccine• have ever fainted in association with an injection
Additional side effects that have been reported with COMIRNATY or Pfizer-BioNTech COVID-19 vaccines include:• Non-severe allergic reactions such as rash, itching, hives, or swelling of the face
• Injection site reactions: pain, swelling, redness, arm pain
• General side effects: tiredness, headache, muscle pain, chills, joint pain, fever, nausea, feeling unwell,lymph nodes (lymphadenopathy), decreased appetite, diarrhea, vomiting, dizziness
These may not be all the possible side effects of COMIRNATY. Ask your healthcare provider about any side effects that concern you.
You may report side effects to the FDA/CDC Vaccine Adverse Event Reporting System (VAERS). The VAERS toll-free number is
1-800-822-7967 or report online to www.vaers.hhs.gov/reportevent.html.
In addition, you can report side effects to Pfizer Inc. at 1-800-438-1985 or www.pfizersafetyreporting.com.

Indication
COMIRNATY® (COVID-19 Vaccine, mRNA) is a vaccine for use in people 12 years of age and older to protect against
coronavirus disease 2019 (COVID-19).
Please click here for full Prescribing Information and Patient Information for COMIRNATY.

© 2024 Pfizer Inc.

All rights reserved.

PP-CVV-USA-4411

August 2024